Grayscale’s ETF Push Could Make DOGE A 500 Billion-Dollar Asset, But Analyst Backs This Other Coin As The Wiser Bet

0 0 3 minutes read

grayscale’s-etf-push-could-make-doge-a-500-billion-dollar-asset,-but-analyst-backs-this-other-coin-as-the-wiser-bet

The world’s focus recently shifted to Dogecoin (DOGE) since Grayscale and Bitwise started advocating for a Dogecoin exchange-traded fund (ETF). If this were to push through, we could see many more institutional buyers due to its growing potential, increasing the market cap to an astonishing $500 billion. Nevertheless, as exciting as it sounds, most analysts are looking toward Dogecoin’s altcoin competition. Rexas Finance (RXS) seems to be leading the path with the most significant opportunities in the market for real-world asset tokenization.

The Race for the Dogecoin ETF – A Paradigm Shift or More of the Same?

The talk and focus on the Dogecoin ETF are starting to increase, capturing the interest of more investors. As of mid-February, the SEC confirmed receipt of Grayscale’s document submission on February 14, 2025, which was greatly unpublicized. Maybe now there is a reason for excitement, as DOGE’s price surpassed $0.27. If the ETF does receive approval, it will boost institutional investment, similar to how Bitcoin and Ethereum ETFs did. Analysts at Bloomberg have projected a 75% likelihood of approval for the Dogecoin ETF this year, which is higher than Solana’s projection of 70%. Should the approval go through, Dogecoin could witness tremendous growth beyond its all-time high of $0.48 in December 2024 and reach the $1 range. Regardless of the optimism, Dogecoin remains a highly speculative asset with the least utility globally. Unlike other top-tier cryptocurrencies, DOGE does not have a use case apart from being a meme cryptocurrency. Hence, RXS is the much wiser bet.

Rexas Finance (RXS): The Altcoin Analysts’ Favorite Pick

Even as Dogecoin appears in the news, wiser investors are considering Rexas Finance (RXS) as a more viable option. Contrary to DOGE, which relies more on speculation and hype, RXS is entrenched in the to-be concept of RWA or Real-World Asset Tokenization. In its last presale stage (Stage 12), the RXS presale price was $0.20. So far, it has raised $46.5 million and sold 452.9 million tokens. The presale is 90.58% complete, and the token will be listed on major exchanges at $0.25 on June 19, 2025.

Why RXS Is the Smarter Investment Over DOGE

The tokenization of real-world assets has recently become an increasingly adopted trend in blockchain technology. RXS allows investors to purchase a fraction of a high-value item, whether real estate or a commodity, without brokers, significantly increasing market liquidity. This use case gives RXS an edge over Dogecoin and other meme-based currencies. Additionally, institutional investors are looking into RWA tokenization as a hedge against inflation and volatility in traditional markets. With RXS undergoing the presale and clear regulatory frameworks emerging for asset-backed tokens, RXS will experience increased demand and moderate price volatility after the listing.

Possible Price Movement for RXS and DOGE

Forecasts place the price of Dogecoin at around $1 in late 2025, suggesting a significant surge in price after approval. However, with the ETF’s conditionality on hype cycles, DOGE remains a high-risk asset with a negative long-term prognosis. With the additional support of a functioning product, RXS has a more defined growth structure. Analysts predict that RXS could rally from $0.25 at the upcoming exchange listing to $5 in the short term and potentially $20 within two years. Bear in mind that this is a 100x return from the presale price and certainly far exceeds the opportunity Dogecoin provides.

Conclusion: Better Take Caution When Investing in RXS for 2025

Considering the ETF push, Dogecoin’s valuation could rise significantly. However, how long it will last is an entirely different question. Due to the social media-driven characteristics of meme coins, they greatly alter the risks serious investors take. On the other hand, RXS makes for a more appealing investment, especially with its technology in asset tokenization. People searching for crypto investments with high growth potential need to look no further than RXS. As institutional interest in RWA tokenization rises, RXS will surpass Dogecoin’s growth rate, possibly becoming one of the best-performing tokens of 2025 and beyond. Considering it is set to be listed on June 19, 2025, this may be the last opportunity to buy in before the token skyrockets in value.

For more information about Rexas Finance (RXS) visit the links below: